CEO Charlene Liao (Immune-Onc)
Going head-to-head with Merck on I/O, Genentech vets raise fresh round and enter clinic
Three years after convincing two ex-Genentech colleagues to join her on a hunt of a new form of immuno-oncology, Charlene Liao and her startup …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
